Eve CostopoulosVice President, Chief Ethics & Compliance Officer Eisai
Lauran S. D’AlessioVice President US Market Business Practices & Compliance, Merck
Justin A. DillonVice President, Chief Ethics & Compliance Officer Ipsen Biopharmaceuticals
Adriana MosailovDirector of Corporate Compliance & Business Practices Endo Pharmaceuticals
The outcome of the Pfizer settlement and latest investigations, such as the Teva Pharmaceuticals investigation, demonstrate the very real threat you face of violating the FCPA. Don’t become complacent. Make sure you are applying the most innovative measures and strategies to maintain a robust compliance program.
The increasing focus of enforcement agencies on the pharmaceutical industry creates a critical need to receive the most current advice on FCPA enforcement trends and industry best practices.
Hanson Wade’s Pharmaceutical Anti-Corruption Compliance meeting brings together senior compliance, legal, audit and logistics representatives to address the urgent compliance challenges faced by your high risk industry. The exclusive focus on the pharmaceutical industry means every piece of intelligence is tailored to address the specific challenges you face.
Attend this conference to protect yourself from enforcement action. You’ll leave armed with tangible intelligence and action points to establish a pro-active anti-corruption compliance program.
Attend Pharmaceutical Anti-Corruption Compliance and:
Download the brochure to see more detail on how the program is shaping up
Let us know if you’ve got material that you’re interested in presenting as there are opportunities to speak or sponsor
Register now and secure your place early and take advantage of the early registration discounts
“Outstanding…Excellent presentations, variety, very good organisation, great networking sessions. Thanks for preparing and please repeat next year!” GSK
“Best of the best compliance conferences that I have attended in the last three years” Panalpina